AstraZeneca profit jumps 23% on cancer drugs as it unveils major savings plan
· euronews.com · popularity 14/100 · 0 similar stories today · Cancer & Oncology (Health & Life Sciences)
Read the original at euronews.com →
Summary
AstraZeneca's net profit jumped 23% in the third quarter on booming sales of its cancer drugs, as the British drugmaker unveiled a programme to save $1.5 billion (€1.34bn) a year to invest back into developing new medicines.
Found in: Euronews. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 23.